Dr. Pengfei Qiu 邱鹏飞
Chief Physician
Department of Breast Surgery I, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive breast lesion treatment, breast-conserving and reconstructive surgery, sentinel lymph node biopsy, neoadjuvant therapy, comprehensive early-stage care, and palliative care for advanced breast cancer.
Dr. Qiu holds an MD and serves as Deputy Director of Breast Surgery Ward 1 at Shandong Cancer Hospital. A former visiting scholar at the University of Cambridge and UK National Cancer Research Centre, Dr. Qiu leads over 10 research projects and has published more than 30 papers.
Professional roles
- Member, Chinese Medical Association
- Young Committee Member, Breast Cancer Group, Oncology Branch, Chinese Medical Association
- Young Expert, Breast Cancer Professional Committee, China Anti-Cancer Association
- Member, International Medical Exchange Branch, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Qiu Pengfei). Papers usually list the name as Pengfei Qiu or Qiu P.
Selected publications
62 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Biol Med, 2025 (senior author): Impact of pre-neoadjuvant radioactive iodine seed marking on pathologic complete response and survival in early-stage breast cancer patients. PubMed 41454490
- Front Oncol, 2025 (senior author): Analysis of survival differences in advanced triple-negative breast cancer: a real-world study. PubMed 40896426
- Cancer Biol Med, 2025 (senior author): Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy. PubMed 40611581
- BMC Cancer, 2025 (senior author): Exploring the clinical value of regional nodal irradiation in sentinel lymph node positive breast cancer patients omitting axillary dissection. PubMed 40361063
- Chin J Cancer Res, 2025 (senior author): Optimizing management of sentinel lymph node limited residual tumor after neoadjuvant therapy for breast cancer: Balancing of act. PubMed 40353084
- Cancer Biol Med, 2025 (senior author): Antibody-drug conjugates in breast cancer: advances and prospects. PubMed 39960255
- Eur J Surg Oncol, 2023 (first author): Development and validation of a nomogram for predicting internal mammary sentinel node metastasis in breast cancer patients. PubMed 37672825
- Lancet Oncol, 2021 (first author): Indications for individual internal mammary node irradiation. PubMed 33539747
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion